NO20051561L - Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine. - Google Patents
Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine.Info
- Publication number
- NO20051561L NO20051561L NO20051561A NO20051561A NO20051561L NO 20051561 L NO20051561 L NO 20051561L NO 20051561 A NO20051561 A NO 20051561A NO 20051561 A NO20051561 A NO 20051561A NO 20051561 L NO20051561 L NO 20051561L
- Authority
- NO
- Norway
- Prior art keywords
- nucleic acid
- acid molecules
- human papillomavirus
- molecules encoding
- vaccine
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 241000701806 Human papillomavirus Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 108010041986 DNA Vaccines Proteins 0.000 abstract 1
- 229940021995 DNA vaccine Drugs 0.000 abstract 1
- 208000009608 Papillomavirus Infections Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Foreliggende oppfinnelse angår fremgangsmåter og preparater egnet ved behandling og forebygging av infeksjoner med humant papillomavims. Spesielt angår oppfinnelsen nukleinsyremolekyler som koder for El og/eller E2 og vektorer egnet for DNA-vaksineavgivelse, og farmasøytiske preparater inneholdende dem. Fremgangsmåter for fremstilling av disse molekyler, vektorer og preparater er også påtenkt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0222953.2A GB0222953D0 (en) | 2002-10-03 | 2002-10-03 | Novel Compounds |
PCT/EP2003/011158 WO2004031222A2 (en) | 2002-10-03 | 2003-10-01 | Dna vaccine encoding at least two nonstructural early proteins of papillomavirus |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20051561D0 NO20051561D0 (no) | 2005-03-23 |
NO20051561L true NO20051561L (no) | 2005-06-02 |
Family
ID=9945247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20051561A NO20051561L (no) | 2002-10-03 | 2005-03-23 | Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine. |
Country Status (21)
Country | Link |
---|---|
US (2) | US20060165713A1 (no) |
EP (1) | EP1546191A2 (no) |
JP (1) | JP2006516386A (no) |
KR (1) | KR20050050115A (no) |
CN (1) | CN100393878C (no) |
AR (1) | AR041515A1 (no) |
AU (1) | AU2003294672A1 (no) |
BR (1) | BR0314986A (no) |
CA (1) | CA2500093A1 (no) |
CO (1) | CO5580837A2 (no) |
GB (1) | GB0222953D0 (no) |
IS (1) | IS7775A (no) |
MA (1) | MA27474A1 (no) |
MX (1) | MXPA05003558A (no) |
NO (1) | NO20051561L (no) |
NZ (1) | NZ539154A (no) |
PL (1) | PL376534A1 (no) |
RU (1) | RU2354701C2 (no) |
TW (1) | TW200411055A (no) |
WO (1) | WO2004031222A2 (no) |
ZA (1) | ZA200503201B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1556077A2 (en) | 2002-10-29 | 2005-07-27 | Coley Pharmaceutical Group, Ltd | Use of cpg oligonucleotides in the treatment of hepatitis c virus infection |
CN101617052A (zh) * | 2007-01-30 | 2009-12-30 | 特兰斯吉恩股份有限公司 | 用于免疫的乳头瘤病毒e2多肽 |
GB0710538D0 (en) * | 2007-06-01 | 2007-07-11 | Glaxo Group Ltd | Vaccine |
EP2585107B1 (en) | 2010-06-25 | 2018-10-24 | Vaccibody AS | Homodimeric protein constructs |
MY195018A (en) * | 2014-10-24 | 2023-01-03 | Hpvvax Llc | Cancer and skin lesion treatment |
US20190134190A1 (en) * | 2016-05-04 | 2019-05-09 | Transgene Sa | Combination therapy with cpg tlr9 ligand |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN443995A0 (en) * | 1995-07-27 | 1995-08-17 | Csl Limited | Papillomavirus polyprotein |
WO2002008435A1 (en) * | 2000-07-21 | 2002-01-31 | Glaxo Group Limited | Codon-optimized papilloma virus sequences |
GB0017990D0 (en) * | 2000-07-21 | 2000-09-13 | Glaxo Group Ltd | Papilloma virus sequences |
-
2002
- 2002-10-03 GB GBGB0222953.2A patent/GB0222953D0/en not_active Ceased
-
2003
- 2003-10-01 AU AU2003294672A patent/AU2003294672A1/en not_active Abandoned
- 2003-10-01 CA CA002500093A patent/CA2500093A1/en not_active Abandoned
- 2003-10-01 NZ NZ539154A patent/NZ539154A/en unknown
- 2003-10-01 WO PCT/EP2003/011158 patent/WO2004031222A2/en active Application Filing
- 2003-10-01 BR BR0314986-2A patent/BR0314986A/pt not_active IP Right Cessation
- 2003-10-01 US US10/529,931 patent/US20060165713A1/en not_active Abandoned
- 2003-10-01 PL PL376534A patent/PL376534A1/pl not_active Application Discontinuation
- 2003-10-01 EP EP03785608A patent/EP1546191A2/en not_active Withdrawn
- 2003-10-01 MX MXPA05003558A patent/MXPA05003558A/es not_active Application Discontinuation
- 2003-10-01 JP JP2004540797A patent/JP2006516386A/ja active Pending
- 2003-10-01 TW TW092127210A patent/TW200411055A/zh unknown
- 2003-10-01 KR KR1020057005806A patent/KR20050050115A/ko active IP Right Grant
- 2003-10-01 CN CNB2003801049852A patent/CN100393878C/zh not_active Expired - Fee Related
- 2003-10-01 RU RU2005109155/13A patent/RU2354701C2/ru not_active IP Right Cessation
- 2003-10-03 AR ARP030103608A patent/AR041515A1/es unknown
-
2005
- 2005-03-23 NO NO20051561A patent/NO20051561L/no not_active Application Discontinuation
- 2005-03-29 IS IS7775A patent/IS7775A/is unknown
- 2005-04-15 MA MA28223A patent/MA27474A1/fr unknown
- 2005-04-20 ZA ZA200503201A patent/ZA200503201B/en unknown
- 2005-04-28 CO CO05040562A patent/CO5580837A2/es not_active Application Discontinuation
-
2007
- 2007-06-08 US US11/760,127 patent/US20070264283A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2354701C2 (ru) | 2009-05-10 |
CO5580837A2 (es) | 2005-11-30 |
AU2003294672A1 (en) | 2004-04-23 |
GB0222953D0 (en) | 2002-11-13 |
JP2006516386A (ja) | 2006-07-06 |
AR041515A1 (es) | 2005-05-18 |
PL376534A1 (pl) | 2006-01-09 |
MXPA05003558A (es) | 2005-06-03 |
CA2500093A1 (en) | 2004-04-15 |
RU2005109155A (ru) | 2006-03-10 |
KR20050050115A (ko) | 2005-05-27 |
CN100393878C (zh) | 2008-06-11 |
BR0314986A (pt) | 2005-08-09 |
US20070264283A1 (en) | 2007-11-15 |
CN1720261A (zh) | 2006-01-11 |
WO2004031222A3 (en) | 2004-08-19 |
TW200411055A (en) | 2004-07-01 |
EP1546191A2 (en) | 2005-06-29 |
MA27474A1 (fr) | 2005-08-01 |
ZA200503201B (en) | 2006-06-28 |
NO20051561D0 (no) | 2005-03-23 |
WO2004031222A2 (en) | 2004-04-15 |
NZ539154A (en) | 2007-05-31 |
IS7775A (is) | 2005-03-29 |
US20060165713A1 (en) | 2006-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20064584L (no) | Tetrahydropyridoindolderivater | |
BR112021024786A2 (pt) | Construção de rna, sequência de ácido nucleico, cassete de expressão, vetor recombinante, composição farmacêutica, método para preparar a construção de rna, vacina, método para modificar uma célula ex vivo ou in vitro e célula modificada | |
NO20050795L (no) | Forbindelser, blandinger og fremgangsmater for utnyttelse av samme | |
NO20045521L (no) | Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer | |
BRPI0510428A (pt) | composições tópicas de metadona e processos para utilização das mesmas | |
HUP0400231A2 (hu) | Rákos megbetegedések kezelésében különösen hasznos, immundecepcióra szolgáló eljárások és gyógyszerkészítmények | |
TW200507874A (en) | Immunostimulatory nucleic acid oil-in-water formulations and related methods of use | |
HUP0402259A2 (hu) | Vakcinák | |
MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
EP1362127A4 (en) | SERPIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV INFECTION AND THE USE THEREOF | |
NZ543467A (en) | The severe acute respiratory syndrome coronavirus | |
NO20073059L (no) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
NO20052136L (no) | Vaksine mot Hepatitt C-virus (HCV). | |
BRPI0418251C1 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
PL1962815T3 (pl) | Zastosowanie błonotwórczych polimerów do pielęgnacji włosów z grupy poluretanów i zawierające te polimery preparaty i plastry farmaceutyczne | |
NO20051561L (no) | Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine. | |
NO20062948L (no) | Promotere for ekspresjon i modifisert vaccinia-virus Ankara | |
NO20055624L (no) | Tropanderivater og deres anvendelse som Ace-inhibitorer | |
MX2009008118A (es) | Polipeptido e2 del virus del papiloma usado para vacunacion. | |
MX2009004243A (es) | Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal. | |
NO20075815L (no) | Formuleringer og metoder for behandling av amyloidose | |
WO2002078631A3 (en) | Improved conditionally replicating vectors for inhibiting viral infections | |
CL2009000791A1 (es) | Compuestos derivados de labirintopeptina; procedimiento para prepararlos que comprende fermentar la cepa actinomadura namibiensis (dsm 6313); uso de los compuestos para tratar infecciones bacterianas, infecciones viricas y/o dolor; composicion farmaceutica que los comprenden; dna que codifica la preprolabirintopeptina a2. | |
NO20090067L (no) | Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |